> top > docs > PMC:7558914 > spans > 16039-16794 > annotations

PMC:7558914 / 16039-16794 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
384 222-230 Species denotes patients Tax:9606
385 381-389 Species denotes Patients Tax:9606
386 590-598 Species denotes patients Tax:9606
387 39-47 Disease denotes COVID-19 MESH:C000657245
388 78-83 Disease denotes fever MESH:D005334
389 85-92 Disease denotes fatigue MESH:D005221
390 98-103 Disease denotes cough MESH:D003371
391 139-148 Disease denotes pneumonia MESH:D011014
392 213-221 Disease denotes COVID-19 MESH:C000657245
393 369-374 Disease denotes death MESH:D003643
394 423-431 Disease denotes COVID-19 MESH:C000657245
395 627-635 Disease denotes COVID-19 MESH:C000657245

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T28 78-83 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T29 85-92 Phenotype denotes fatigue http://purl.obolibrary.org/obo/HP_0012378
T30 98-103 Phenotype denotes cough http://purl.obolibrary.org/obo/HP_0012735
T31 139-148 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T107 0-251 Sentence denotes The clinical presentation of the novel COVID-19 may vary from mild cases with fever, fatigue, and cough to moderate–severe cases involving pneumonia and multiorgan failure [10], and several factors may predispose COVID-19 patients to adverse outcomes.
T108 252-380 Sentence denotes The older age, critical disease, and high levels of inflammatory markers have been associated with increased risk of death [11].
T109 381-497 Sentence denotes Patients with moderate to severe forms of COVID-19 normally require hospitalizations and pharmacological treatments.
T110 498-644 Sentence denotes However, currently, there is no solid evidence that any potential drug improves outcomes in patients with suspected or confirmed COVID-19 [12,13].
T111 645-755 Sentence denotes Only clinical experience and treatment guidance based on repurposed and experimental treatments are available.